Adastra Pharmaceuticals’ positive results from a Phase Ib trial of its therapy for recurrent high-grade glioblastomas suggest an effective treatment could be available within the next several years. If so, it would be a major breakthrough for patients affected by this lethal disease. The trial evaluated the oral small molecule drug zotiraciclib (ZTR/TG02) in combination […]

As an immigrant, female, mid-30’s CEO in the biotech world, Leen Kawas is used to being told no. She’s familiar with doubts being cast on her ideas, eyebrows raised at her push for innovation and some flat out telling her it won’t work. And she’s comfortable with all of that. It’s that grit that’s gotten […]

Sutro Biopharma wants to use its antibody-drug conjugates (ADCs) as “laser-guided weapons” against cancer cells while sparing the surrounding ones and therefore patients’ quality of life. “I like to think of antibody-drug conjugates as kind of laser-guided weapons against tumor cells. And then what we can do, and Sutro is very focused on this, is […]